[1] Arbour, K. C.; Riely, G. J. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. JAMA 322:764-774; 2019.
[2] Reck, M.; Rabe, K. F. Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. N Engl J Med 377:849-861; 2017.
[3] Shinde, P.; Banerjee, P.; Mandhare, A. Marine natural products as source of new drugs: a patent review (2015-2018). Expert Opin Ther Pat 29:283-309; 2019.
[4] Seca, A. M. L.; Pinto, D. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int J Mol Sci 19; 2018.
[5] Yin, B.; Fang, D. M.; Zhou, X. L.; Gao, F. Natural products as important tyrosine kinase inhibitors. Eur J Med Chem 182:111664; 2019.
[6] Sivakumar, G.; Vail, D. R.; Nair, V.; Medina-Bolivar, F.; Lay, J. O., Jr. Plant-based corosolic acid: future anti-diabetic drug? Biotechnol J 4:1704-1711; 2009.
[7] Jia, M.; Xiong, Y.; Li, M.; Mao, Q. Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma. Oncol Res 28:371-383; 2020.
[8] Zhang, B. Y.; Zhang, L.; Chen, Y. M.; Qiao, X.; Zhao, S. L.; Li, P.; Liu, J. F.; Wen, X.; Yang, J. Corosolic acid inhibits colorectal cancer cells growth as a novel HER2/HER3 heterodimerization inhibitor. Br J Pharmacol; 2021.
[9] Yoo, K. H.; Park, J. H.; Lee, D. Y.; Hwang-Bo, J.; Baek, N. I.; Chung, I. S. Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT-26 Colon Carcinoma Animal Model. Phytother Res 29:714-723; 2015.
[10] Yang, J.; Wu, R.; Li, W.; Gao, L.; Yang, Y.; Li, P.; Kong, A. N. The triterpenoid corosolic acid blocks transformation and epigenetically reactivates Nrf2 in TRAMP-C1 prostate cells. Mol Carcinog 57:512-521; 2018.
[11] Herbst, R. S.; Morgensztern, D.; Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553:446-454; 2018.
[12] Stohs, S. J.; Miller, H.; Kaats, G. R. A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phytother Res 26:317-324; 2012.
[13] Woo, S. M.; Seo, S. U.; Min, K. J.; Im, S. S.; Nam, J. O.; Chang, J. S.; Kim, S.; Park, J. W.; Kwon, T. K. Corosolic Acid Induces Non-Apoptotic Cell Death through Generation of Lipid Reactive Oxygen Species Production in Human Renal Carcinoma Caki Cells. Int J Mol Sci 19; 2018.
[14] Park, J. B.; Lee, J. S.; Lee, M. S.; Cha, E. Y.; Kim, S.; Sul, J. Y. Corosolic acid reduces 5FU chemoresistance in human gastric cancer cells by activating AMPK. Mol Med Rep 18:2880-2888; 2018.
[15] Liu, W. J.; Du, Y.; Wen, R.; Yang, M.; Xu, J. Drug resistance to targeted therapeutic strategies in non-small cell lung cancer. Pharmacol Ther 206:107438; 2020.
[16] Xu, Y.; Zhou, X.; Shi, C.; Wang, J.; Wu, Z. alpha-Lipoic acid protects against the oxidative stress and cytotoxicity induced by cadmium in HepG2 cells through regenerating glutathione regulated by glutamate-cysteine ligase. Toxicol Mech Methods 25:596-603; 2015.
[17] Thangavel, S.; Mulet, C. T.; Atluri, V. S. R.; Agudelo, M.; Rosenberg, R.; Devieux, J. G.; Nair, M. P. N. Oxidative Stress in HIV Infection and Alcohol Use: Role of Redox Signals in Modulation of Lipid Rafts and ATP-Binding Cassette Transporters. Antioxid Redox Signal 28:324-337; 2018.
[18] Wu, C.; Zhao, W.; Yu, J.; Li, S.; Lin, L.; Chen, X. Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells. Sci Rep 8:574; 2018.
[19] Zorov, D. B.; Juhaszova, M.; Sollott, S. J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94:909-950; 2014.
[20] Kang, Z.; Qiao, N.; Liu, G.; Chen, H.; Tang, Z.; Li, Y. Copper-induced apoptosis and autophagy through oxidative stress-mediated mitochondrial dysfunction in male germ cells. Toxicol In Vitro 61:104639; 2019.
[21] Brigelius-Flohe, R.; Flohe, L. Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxid Redox Signal 33:498-516; 2020.
[22] Fang, L.; Du, W. W.; Awan, F. M.; Dong, J.; Yang, B. B. The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis. Cancer Lett 459:216-226; 2019.
[23] Zou, Y.; Ruan, S.; Jin, L.; Chen, Z.; Han, H.; Zhang, Y.; Jian, Z.; Lin, Y.; Shi, N.; Jin, H. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma. Med Sci Monit 26:e925289; 2020.
[24] Park, C.; Cha, H. J.; Lee, H.; Hwang-Bo, H.; Ji, S. Y.; Kim, M. Y.; Hong, S. H.; Jeong, J. W.; Han, M. H.; Choi, S. H.; Jin, C. Y.; Kim, G. Y.; Choi, Y. H. Induction of G2/M Cell Cycle Arrest and Apoptosis by Genistein in Human Bladder Cancer T24 Cells through Inhibition of the ROS-Dependent PI3k/Akt Signal Transduction Pathway. Antioxidants (Basel) 8; 2019.
[25] Huang, D. H.; Jian, J.; Li, S.; Zhang, Y.; Liu, L. Z. TPX2 silencing exerts antitumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway. Int J Mol Med 44:2113-2122; 2019.
[26] Fu, J.; Bian, M.; Xin, G.; Deng, Z.; Luo, J.; Guo, X.; Chen, H.; Wang, Y.; Jiang, Q.; Zhang, C. TPX2 phosphorylation maintains metaphase spindle length by regulating microtubule flux. J Cell Biol 210:373-383; 2015.
[27] Long, N.; Chu, L.; Jia, J.; Peng, S.; Gao, Y.; Yang, H.; Yang, Y.; Zhao, Y.; Liu, J. CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells. Cancer Cell Int 20:374; 2020.